Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer
- 20 February 2006
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 233 (1), 98-107
- https://doi.org/10.1016/j.canlet.2005.03.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Substrate Specificity of MMPsPublished by Springer Science and Business Media LLC ,2003
- Biology and Regulation of the Matrix MetalloproteinasesPublished by Springer Science and Business Media LLC ,2003
- Plasma MMP‐9 (92 kDa‐MMP) activity is useful in the follow‐up and in the assessment of prognosis in breast cancer patientsInternational Journal of Cancer, 2003
- Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancerBritish Journal of Cancer, 2002
- Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression DataJournal of the American Statistical Association, 2002
- Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)Critical Reviews in Biochemistry and Molecular Biology, 2002
- Serum levels of matrix metalloproteinase 2 in patients with breast cancerCancer Letters, 2001
- Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant TherapyBreast Cancer Research and Treatment, 2001
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980